Hopefully this one gets FDA approval in June 2024. I like that their drug Imetelstat is having a prolonged affect of transfusion independence on the 40% of respondents from their phase 3 Imerge Study. I have been adding shares like crazy, as I believe they have the best drug in the world in treating MDS(type of luekemia) and in fact, quadrupled my position in Wadegarret portfolio from 20K to over 80K shares !
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.